Jonathan E. Rothschild - 03 Jun 2021 Form 4 Insider Report for IMMUCELL CORP /DE/ (ICCC)

Reporting relationship: Director
Issuer ticker: ICCC
Reported as of: 03 Jun 2021
Net transaction value: -$78,973
SEC form: 4
Accepted by SEC: 07 Jun 2021, 13:48:30 UTC
Source filing: View source filing
Reporting owner signature: /s/ Michael F Brigham Attorney-in-Fact

Key filing fact

Jonathan E. Rothschild filed Form 4 for IMMUCELL CORP /DE/ (ICCC) on 07 Jun 2021.

Key facts

This page summarizes Jonathan E. Rothschild's Form 4 filing for IMMUCELL CORP /DE/ (ICCC).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Jun 2021, 13:48.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: -$78,973.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ICCC transaction

Common Stock, par value $0.10 per share

Award

Transaction value: $27,223
Shares: +3,845
Change %: +0.75%
Price: $7.08
Shares after: 514,003
Date: 03 Jun 2021
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ICCC transaction Derivative

Incentive Stock Options (Right to buy)

Disposed to Issuer

Transaction value: $106,196
Shares: -11,155
Change %: -100%
Price: $9.52
Shares after: 0
Date: 03 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,155
Exercise price: $9.52

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These holdings include 226,416 shares of common stock held by Arterio, Inc., a corporation owned solely by Mr. Rothschild

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .